Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Neoplasms × Esomeprazole × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Other neoplasm 1

Conditions

Precancerous Conditions 1 Esophageal Neoplasms 1 Barrett Esophagus 1

Interventions

Endoscopy 2 Biopsy 2 Immunohistochemistry 1 High-Throughput Screening Assays 1 Genetic Linkage 1 Esomeprazole 1 Erlotinib Hydrochloride 1 Endoscopy, Digestive System 1 Endoscopic Mucosal Resection 1 Comparative Genomic Hybridization 1 Aspirin 1 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00357682 2025-05-01

AspECT

University of Oxford

Phase 3 Completed

2,557 enrolled 17 charts

GastrointestinalOther neoplasm

Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡